Net Income (Loss) Attributable to Parent of ALTEROLA BIOTECH INC. from 30 Sep 2010 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
ALTEROLA BIOTECH INC. quarterly and annual Net Income (Loss) Attributable to Parent in USD history and change rate from 30 Sep 2010 to 30 Sep 2024.
  • ALTEROLA BIOTECH INC. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2024 was $799,193, a 549% decline year-over-year.
  • ALTEROLA BIOTECH INC. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2024 was $3,258,125, a 124% decline year-over-year.
  • ALTEROLA BIOTECH INC. annual Net Income (Loss) Attributable to Parent for 2023 was $2,374,379, a 15% decline from 2022.
  • ALTEROLA BIOTECH INC. annual Net Income (Loss) Attributable to Parent for 2022 was $2,071,186, a 504% decline from 2021.
  • ALTEROLA BIOTECH INC. annual Net Income (Loss) Attributable to Parent for 2021 was $343,033, a 11% decline from 2020.
Source SEC data
View on sec.gov
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

ALTEROLA BIOTECH INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $3,258,125 $799,193 -$676,036 -549% 01 Jul 2024 30 Sep 2024 10-Q 29 Nov 2024 2025 Q2
Q2 2024 $2,582,089 $654,747 -$207,710 -46% 01 Apr 2024 30 Jun 2024 10-Q/A 25 Nov 2024 2025 Q1
Q1 2024 $2,374,379 $206,137 +$554,593 01 Jan 2024 31 Mar 2024 10-K 18 Jul 2024 2024 FY
Q4 2023 $2,928,972 $2,010,322 -$1,475,533 -276% 01 Oct 2023 31 Dec 2023 10-Q/A 21 Feb 2024 2024 Q3
Q3 2023 $1,453,439 $123,157 +$252,095 +67% 01 Jul 2023 30 Sep 2023 10-Q 29 Nov 2024 2025 Q2
Q2 2023 $1,705,534 $447,037 +$365,652 +45% 01 Apr 2023 30 Jun 2023 10-Q/A 25 Nov 2024 2025 Q1
Q1 2023 $2,071,186 $348,456 +$5,985,958 +94% 01 Jan 2023 31 Mar 2023 10-K 18 Jul 2024 2024 FY
Q4 2022 $8,057,144 $534,789 +$2,265,888 +81% 01 Oct 2022 31 Dec 2022 10-Q/A 21 Feb 2024 2024 Q3
Q3 2022 $10,323,032 $375,252 -$113,174 -43% 01 Jul 2022 30 Sep 2022 10-Q 21 Nov 2023 2024 Q2
Q2 2022 $10,209,858 $812,689 -$662,129 -440% 01 Apr 2022 30 Jun 2022 10-Q 15 Aug 2023 2024 Q1
Q1 2022 $9,547,729 $6,334,414 -$5,991,381 -1747% 01 Jan 2022 31 Mar 2022 10-Q 14 Feb 2023 2023 Q3
Q4 2021 $3,556,348 $2,800,677 -$2,738,677 -4417% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q3
Q3 2021 $817,671 $262,078 01 Jul 2021 30 Sep 2021 10-Q 21 Nov 2022 2023 Q2
Q2 2021 $150,560 01 Apr 2021 30 Jun 2021 10-Q 18 Aug 2022 2023 Q1
Q1 2021 $343,033 07 Jan 2021 31 Mar 2021 10-K/A 14 Sep 2022 2022 FY
Q4 2020 $62,000 -$36,307 -141% 01 Oct 2020 31 Dec 2020 10-Q 28 May 2021 2021 Q1
Q4 2019 $25,693 +$26,943 +51% 01 Oct 2019 31 Dec 2019 10-Q 02 Apr 2021 2020 Q1
Q4 2018 $52,636 01 Oct 2018 31 Dec 2018 10-Q 29 Dec 2020 2019 Q1

ALTEROLA BIOTECH INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $2,374,379 -$303,193 -15% 01 Apr 2023 31 Mar 2024 10-K 18 Jul 2024 2024 FY
2022 $2,071,186 -$1,728,153 -504% 01 Apr 2022 31 Mar 2023 10-K 18 Jul 2024 2024 FY
2021 $343,033 -$33,533 -11% 19 Jan 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q3
2020 $309,500 -$50,798 -20% 01 Apr 2020 31 Mar 2021 10-K/A 14 Sep 2022 2022 FY
2019 $258,702 -$145,635 -129% 01 Oct 2018 30 Sep 2019 10-KT 09 Jun 2021 2021 FY
2018 $113,067 -$45,435 -67% 01 Oct 2017 30 Sep 2018 10-K 26 Mar 2021 2019 FY
2017 $67,632 -$45,055 -200% 01 Oct 2016 30 Sep 2017 10-Q 29 Dec 2020 2019 Q1
2016 $22,577 +$13,550 +38% 01 Oct 2015 30 Sep 2016 10-Q 29 Dec 2020 2019 Q1
2015 $36,127 +$18,788 +34% 01 Oct 2014 30 Sep 2015 10-K 30 Dec 2015 2015 FY
2014 $54,915 +$17,586 +24% 01 Oct 2013 30 Sep 2014 10-K 30 Dec 2015 2015 FY
2013 $72,501 -$59,251 -447% 01 Oct 2012 30 Sep 2013 10-K 13 Jan 2015 2014 FY
2012 $13,250 +$92,862 +88% 01 Oct 2011 30 Sep 2012 10-K 13 May 2014 2013 FY
2011 $106,112 +$22,759 +18% 01 Oct 2010 30 Sep 2011 10-K 13 May 2014 2013 FY
2010 $128,871 01 Oct 2009 30 Sep 2010 10-K 13 May 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.